Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| OMER | NASDAQ | Omeros Corporation | $9.79 | -4.77% | 797K | $708.55M |
| BBOT | NASDAQ | BridgeBio Oncology Therapeutics Inc. | $8.32 | -8.47% | 186K | $706.54M |
| BBNX | NASDAQ | Beta Bionics, Inc. | $17.29 | +2.31% | 559K | $706.3M |
| CADL | NASDAQ | Candel Therapeutics, Inc. | $9.49 | -4.04% | 1M | $700.46M |
| DRUG | NASDAQ | Bright Minds Biosciences Inc. | $71.33 | +0.06% | 346K | $698.12M |
| SSII | NASDAQ | SS Innovations International, Inc. | $3.48 | -2.66% | 145K | $695.46M |
| EVO | NASDAQ | Evotec SE | $1.94 | -2.02% | 34K | $689.06M |
| SGP | NASDAQ | SpyGlass Pharma, Inc. Common Stock | $19.77 | -4.77% | 104K | $685.05M |
| RIGL | NASDAQ | Rigel Pharmaceuticals, Inc. | $36.74 | -0.22% | 485K | $679.77M |
| ANL | NASDAQ | Adlai Nortye Ltd. | $12.50 | -5.45% | 131K | $663.5M |
| ESPR | NASDAQ | Esperion Therapeutics, Inc. | $3.18 | 0.00% | 0 | $661.15M |
| JBIO | NASDAQ | Jade Biosciences, Inc. | $20.86 | +1.86% | 685K | $655.13M |
| CBLL | NASDAQ | CeriBell, Inc. | $16.91 | +3.87% | 363K | $641.61M |
| OCS | NASDAQ | Oculis Holding AG | $12.19 | -3.33% | 375K | $636.3M |
| BWAY | NASDAQ | BrainsWay Ltd. | $16.51 | -0.30% | 295K | $626.39M |
| ACHV | NASDAQ | Achieve Life Sciences, Inc. | $6.10 | -1.13% | 927K | $626.22M |
| MDXG | NASDAQ | MiMedx Group, Inc. | $4.08 | -0.73% | 532K | $625.57M |
| TCMD | NASDAQ | Tactile Systems Technology, Inc. | $27.48 | +0.15% | 197K | $619.85M |
| CRMD | NASDAQ | CorMedix Inc. | $7.87 | -2.24% | 625K | $617.42M |
| AGMB | NASDAQ | AgomAb Therapeutics N.V. American Depositary Shares | $12.51 | -3.55% | 59K | $616.09M |
| IRWD | NASDAQ | Ironwood Pharmaceuticals, Inc. | $3.71 | -2.11% | 1.1M | $610.71M |
| ALLO | NASDAQ | Allogene Therapeutics, Inc. | $1.74 | -4.40% | 4.9M | $600.57M |
| SPRY | NASDAQ | ARS Pharmaceuticals, Inc. | $5.94 | -1.00% | 3.5M | $589.86M |
| CERS | NASDAQ | Cerus Corporation | $2.93 | +2.09% | 2.5M | $587.08M |
| CTKB | NASDAQ | Cytek Biosciences, Inc. | $4.62 | +0.65% | 597K | $575.98M |
| TECX | NASDAQ | Tectonic Therapeutic, Inc. | $34.37 | -2.55% | 99K | $573.06M |
| ODTX | NASDAQ | Odyssey Therapeutics, Inc. | $16.69 | -0.83% | 161K | $564.07M |
| ZVRA | NASDAQ | Zevra Therapeutics, Inc. | $13.24 | +0.48% | 6.9M | $563.07M |
| ANGO | NASDAQ | AngioDynamics, Inc. | $13.59 | +1.12% | 333K | $561.71M |
| FLGT | NASDAQ | Fulgent Genetics, Inc. | $19.67 | -1.55% | 146K | $558.64M |
| NGNE | NASDAQ | Neurogene Inc. | $37.31 | +2.22% | 162K | $551.5M |
| RLMD | NASDAQ | Relmada Therapeutics, Inc. | $5.18 | -0.38% | 1.6M | $543.33M |
| GYRE | NASDAQ | Gyre Therapeutics, Inc. | $5.94 | -1.16% | 34K | $542.86M |
| MLAB | NASDAQ | Mesa Laboratories, Inc. | $97.50 | -3.42% | 121K | $538.68M |
| PRME | NASDAQ | Prime Medicine, Inc. | $3.13 | -2.80% | 2.4M | $532.82M |
| VSTM | NASDAQ | Verastem, Inc. | $6.18 | +4.92% | 2.5M | $531.64M |
| MYGN | NASDAQ | Myriad Genetics, Inc. | $5.61 | -1.58% | 868K | $529.85M |
| FDMT | NASDAQ | 4D Molecular Therapeutics, Inc. | $10.07 | -2.99% | 682K | $526.42M |
| CTNM | NASDAQ | Contineum Therapeutics, Inc. | $15.19 | -1.68% | 123K | $525.65M |
| CTMX | NASDAQ | CytomX Therapeutics, Inc. | $3.24 | -2.70% | 1.5M | $521.07M |
| SLN | NASDAQ | Silence Therapeutics plc | $9.09 | -7.81% | 341K | $520.52M |
| ARVN | NASDAQ | Arvinas, Inc. | $8.01 | -0.25% | 386K | $518.11M |
| NVCT | NASDAQ | Nuvectis Pharma, Inc. | $19.31 | -4.17% | 248K | $512.42M |
| NPCE | NASDAQ | NeuroPace, Inc. | $14.54 | -0.27% | 269K | $504.93M |
| PROK | NASDAQ | ProKidney Corp. | $1.50 | -1.32% | 1.7M | $504.38M |
| RGNX | NASDAQ | REGENXBIO Inc. | $9.73 | -5.07% | 974K | $503.02M |
| TOI | NASDAQ | The Oncology Institute, Inc. | $5.89 | +0.68% | 1.2M | $497.91M |
| ZURA | NASDAQ | Zura Bio Limited | $5.23 | -1.13% | 366K | $496.84M |
| KIDS | NASDAQ | OrthoPediatrics Corp. | $18.87 | +0.80% | 142K | $484.68M |
| RZLT | NASDAQ | Rezolute, Inc. | $4.61 | +5.49% | 1.1M | $480.5M |